These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35380689)

  • 1. Biphasic Waning of Hemagglutination Inhibition Antibody Titers After Influenza Vaccination in Children.
    Xiong W; Tsang TK; Perera RAPM; Leung NHL; Fang VJ; Barr IG; Malik Peiris JS; Cowling BJ
    J Infect Dis; 2022 Sep; 226(6):1022-1026. PubMed ID: 35380689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples.
    Otani N; Nakajima K; Ishikawa K; Ichiki K; Yoda Y; Ueda T; Takesue Y; Yamamoto T; Tanimura S; Shima M; Okuno T
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Waning Immunity at 6 Months after Both Trivalent and Quadrivalent Influenza Vaccination in Korean Children Aged 6-35 Months.
    Lee JH; Cho HK; Kim KH; Lee J; Kim YJ; Eun BW; Kim NH; Kim DH; Jo DS; Kim HM; Kim YK
    J Korean Med Sci; 2019 Dec; 34(46):e279. PubMed ID: 31779056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children.
    Moehling KK; Zimmerman RK; Nowalk MP; Jeng Lin C; Martin JM; Alcorn JF; Susick M; Burroughs A; Holiday C; Flannery B; Levine MZ
    Vaccine; 2020 Jul; 38(33):5171-5177. PubMed ID: 32580919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children.
    Ng S; Fang VJ; Ip DK; Chan KH; Leung GM; Peiris JS; Cowling BJ
    J Infect Dis; 2013 Oct; 208(8):1320-4. PubMed ID: 23908481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Immune Priming, Vaccination, and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
    Hinojosa M; Shepard SS; Chung JR; King JP; McLean HQ; Flannery B; Belongia EA; Levine MZ
    J Infect Dis; 2021 Aug; 224(3):469-480. PubMed ID: 33090202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza B.
    Cowling BJ; Lim WW; Perera RAPM; Fang VJ; Leung GM; Peiris JSM; Tchetgen Tchetgen EJ
    Clin Infect Dis; 2019 May; 68(10):1713-1717. PubMed ID: 30202873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season.
    Ganczak M; Dubiel P; Drozd-Dąbrowska M; Hallmann-Szelińska E; Szymański K; Brydak LB
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31739554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera.
    Xie H; Li L; Ye Z; Li X; Plant EP; Zoueva O; Zhao Y; Jing X; Lin Z; Kawano T; Chiang MJ; Finch CL; Kosikova M; Zhang A; Zhu Y; Wan XF
    Clin Infect Dis; 2017 Jul; 65(2):259-267. PubMed ID: 28369230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
    Dawood FS; Naleway AL; Flannery B; Levine MZ; Murthy K; Sambhara S; Gangappa S; Edwards L; Ball S; Grant L; Belongia E; Bounds K; Cao W; Gross FL; Groom H; Fry AM; Rentz Hunt D; Jeddy Z; Mishina M; Kim SS; Wesley MG; Spencer S; Thompson MG; Gaglani M
    Clin Infect Dis; 2021 Dec; 73(11):1973-1981. PubMed ID: 34245243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial.
    Niang M; Deming ME; Goudiaby D; Diop OM; Dia N; Diallo A; Ortiz JR; Diop D; Lewis KDC; Lafond KE; Widdowson MA; Victor JC; Neuzil KM
    Vaccine; 2020 Nov; 38(47):7526-7532. PubMed ID: 33012603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.
    Tsurudome Y; Kimachi K; Okada Y; Matsuura K; Ooyama Y; Ibaragi K; Kino Y; Ueda K
    Microbiol Immunol; 2015 Oct; 59(10):597-604. PubMed ID: 26272602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
    Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
    Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.
    McLean HQ; Levine MZ; King JP; Flannery B; Belongia EA
    Vaccine; 2021 Dec; 39(49):7146-7152. PubMed ID: 34774360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults.
    Spencer S; Chung JR; Belongia EA; Sundaram M; Meece J; Coleman LA; Zimmerman RK; Nowalk MP; Moehling Geffel K; Ross T; Carter CE; Shay D; Levine M; Liepkalns J; Kim JH; Sambhara S; Thompson MG; Flannery B
    Influenza Other Respir Viruses; 2022 May; 16(3):562-567. PubMed ID: 34859584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness.
    Meng Z; Zhang J; Shi J; Zhao W; Huang X; Cheng L; Yang X
    Hum Vaccin Immunother; 2020 Nov; 16(11):2680-2689. PubMed ID: 32347787
    [No Abstract]   [Full Text] [Related]  

  • 19. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.
    Ohmit SE; Petrie JG; Cross RT; Johnson E; Monto AS
    J Infect Dis; 2011 Dec; 204(12):1879-85. PubMed ID: 21998477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning.
    Zelner J; Petrie JG; Trangucci R; Martin ET; Monto AS
    J Infect Dis; 2019 Jun; 220(1):12-19. PubMed ID: 30722022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.